Literature DB >> 2221137

Roles of interleukin 1 beta and tumor necrosis factor in lipopolysaccharide fever in rats.

N C Long1, I Otterness, S L Kunkel, A J Vander, M J Kluger.   

Abstract

The roles of interleukin 1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF) in lipopolysaccharide (LPS)-induced fever were investigated in the rat. We used antisera against IL-1 beta and TNF to determine whether we could alter the fever by blocking the action of these cytokines. The intravenous injection of antiserum IL-1 beta 3.5 days before the intraperitoneal injection of LPS resulted in a mean fever that was significantly lower than that seen in rats that had been injected with control serum (0.36 +/- 0.11 vs. 0.82 +/- 0.16 degrees C, P = 0.016). The intravenous injection of antiserum against TNF 3.5 days before the intraperitoneal injection of LPS did not block the fever but significantly enhanced it (1.31 +/- 0.16 vs. 0.82 +/- 0.16 degrees C, P = 0.027). These data support the hypotheses that IL-1 beta is responsible for a significant part of LPS fever and that TNF acts as an endogenous antipyretic to limit the magnitude of LPS fever in the rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221137     DOI: 10.1152/ajpregu.1990.259.4.R724

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  Hypothalamic interaction between macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta in rats: a new level for fever control?

Authors:  F J Miñano; A Fernández-Alonso; R D Myers; M Sancibrián
Journal:  J Physiol       Date:  1996-02-15       Impact factor: 5.182

2.  Prenatal opiate exposure attenuates LPS-induced fever in adult rats: role of interleukin-1beta.

Authors:  Kathryn L Hamilton; La 'Tonyia M Franklin; Sabita Roy; Lisa M Schrott
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

3.  Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies with interleukin-1beta and tumor necrosis factor-alpha.

Authors:  X Y Hua; P Chen; A Fox; R R Myers
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

4.  Role of central interleukin-1 beta in gastrointestinal motor disturbances induced by lipopolysaccharide in sheep.

Authors:  M A Plaza; J Fioramonti; L Bueno
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

5.  Diet-induced obesity attenuates the hypothermic response to lipopolysaccharide independently of TNF-α production.

Authors:  Evilin N Komegae; Monique T Fonseca; Alexandre A Steiner
Journal:  Temperature (Austin)       Date:  2020-01-09

6.  A novel animal model to study hot flashes: no effect of gonadotropin-releasing hormone.

Authors:  Asher J Albertson; Donal C Skinner
Journal:  Menopause       Date:  2009 Sep-Oct       Impact factor: 2.953

7.  Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats.

Authors:  A M Karkar; Y Koshino; S J Cashman; A C Dash; J Bonnefoy; A Meager; A J Rees
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

8.  A mechanism for the inhibition of fever by a virus.

Authors:  A Alcamí; G L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.

Authors:  E Fischer; M A Marano; K J Van Zee; C S Rock; A S Hawes; W A Thompson; L DeForge; J S Kenney; D G Remick; D C Bloedow
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

10.  Rapidly activated microglial cells in the preoptic area may play a role in the generation of hyperthermia following occlusion of the middle cerebral artery in the rat.

Authors:  Hajnalka Abrahám; Anikó Somogyvári-Vigh; Jerome L Maderdrut; Sándor Vigh; Akira Arimura
Journal:  Exp Brain Res       Date:  2003-09-12       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.